Nature Communications (Dec 2023)

Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC

  • Danfeng Dong,
  • Yuzhang Du,
  • Xuefeng Fei,
  • Hao Yang,
  • Xiaofang Li,
  • Xiaobao Yang,
  • Junrui Ma,
  • Shu Huang,
  • Zhihui Ma,
  • Juanjuan Zheng,
  • David W. Chan,
  • Liyun Shi,
  • Yunqi Li,
  • Aaron T. Irving,
  • Xiangliang Yuan,
  • Xiangfan Liu,
  • Peihua Ni,
  • Yiqun Hu,
  • Guangxun Meng,
  • Yibing Peng,
  • Anthony Sadler,
  • Dakang Xu

DOI
https://doi.org/10.1038/s41467-023-43945-1
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Inflammasome activity is important for the immune response and is instrumental in numerous clinical conditions. Here we identify a mechanism that modulates the central Caspase-1 and NLR (Nod-like receptor) adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD). We show that the function of ASC in assembling the inflammasome is controlled by its modification with SUMO (small ubiquitin-like modifier) and identify that the nuclear ZBTB16 (zinc-finger and BTB domain-containing protein 16) promotes this SUMOylation. The physiological significance of this activity is demonstrated through the reduction of acute inflammatory pathogenesis caused by a constitutive hyperactive inflammasome by ablating ZBTB16 in a mouse model of Muckle-Wells syndrome. Together our findings identify an further mechanism by which ZBTB16-dependent control of ASC SUMOylation assembles the inflammasome to promote this pro-inflammatory response.